ID   Nakajima
AC   CVCL_A1TQ
SY   NAKAJIMA
DR   ChEMBL-Cells; CHEMBL3307303
DR   ChEMBL-Targets; CHEMBL614134
DR   Wikidata; Q105510274
RX   CelloPub=CLPUB00594;
RX   PubMed=14766244;
RX   PubMed=18720132;
CC   Population: Japanese.
DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma
DI   ORDO; Orphanet_454723; Endometrioid carcinoma of ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
CA   Cancer cell line
DT   Created: 12-01-21; Last updated: 21-03-23; Version: 3
//
RX   CelloPub=CLPUB00594;
RA   Aoki Y., Adachi S., Yoshiya N., Honma S., Kanazawa K.;
RT   "Establishment and characterization of human ovarian endometrioid
RT   carcinoma cell line.";
RL   Hum. Cell 2 Suppl. 1:46-46(1989).
//
RX   PubMed=14766244; DOI=10.1016/j.ygyno.2003.10.047;
RA   Tamura M., Takakuwa K., Tanaka K.;
RT   "Cis-diamminedichloroplatinum-resistant cell lines derived from human
RT   epithelial ovarian carcinoma express increased susceptibility to
RT   angiogenesis inhibitor TNP-470.";
RL   Gynecol. Oncol. 92:530-536(2004).
//
RX   PubMed=18720132; DOI=10.1080/10717540802329183;
RA   Serikawa T., Kikuchi H., Oite T., Tanaka K.;
RT   "Enhancement of gene expression efficiency using cationic liposomes on
RT   ovarian cancer cells.";
RL   Drug Deliv. 15:523-529(2008).
//